| 注册
首页|期刊导航|中国临床药理学杂志|肾素抑制剂阿利吉仑

肾素抑制剂阿利吉仑

张雅娉 袁洪 黄志军

中国临床药理学杂志2012,Vol.28Issue(3):221-224,4.
中国临床药理学杂志2012,Vol.28Issue(3):221-224,4.

肾素抑制剂阿利吉仑

Direct renin inhibition: Aliskiren

张雅娉 1袁洪 1黄志军1

作者信息

  • 1. 中南大学湘雅三医院心内科,长沙450013
  • 折叠

摘要

Abstract

Aliskiren is an effective antihypertensive drug by inhibiting the renin - angiotensin system. It has a prolonged duration of action and fa-vorable tolerability comparable with placebo. The blood pressure - lower-ing effect of aliskiren monotherapy is similar, if not superior, to that of other first - line antihypertensive agents, and is greatly enhanced when aliskiren is combined with various other antihypertensive medications, without any adverse drug interactions. Aliskiren is also an effective and well tolerated therapy in special populations, including diabetic, obese, and elderly hypertensives. Beyond its blood pressure - lowering efficacy, aliskiren has positive effects on markers of cardiovascular and renal damage.

关键词

肾素抑制剂/阿利吉仑/高血压

Key words

renin inhibitors/aliskiren/hypertension

分类

医药卫生

引用本文复制引用

张雅娉,袁洪,黄志军..肾素抑制剂阿利吉仑[J].中国临床药理学杂志,2012,28(3):221-224,4.

基金项目

国家“重大新药创制”科技重大专项子项目基金资助项目(2009ZX09501-032) (2009ZX09501-032)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量1
|
下载量0
段落导航相关论文